Semaglutide studies found changes in weight, heart risk, and kidney risk.
These late-stage, or phase-3, studies had limits. You'll learn who was tested, what changed, and which questions remain.
The medicine changed blood sugar, hunger, weight, and some health risks
Novo Nordisk set out to copy a gut hormone called GLP-1, which your body sends after meals, and that's how semaglutide began as a medicine affecting the pancreas, stomach, kidneys, heart, and brain. In studies, blood sugar fell, the stomach slowed, and hunger eased. Later work found weight loss along with fewer heart attacks or strokes in some high-risk groups. Kidney damage also slowed in people with diabetes. Those group averages won't foretell your result.
The human studies come first, with their limits stated before the results. Work in animals may help explain appetite, but it can't prove that every brain effect happens in you. Each numbered mark leads to the matching study under references. I'd ask which group is most like you and where the match ends. No study can promise your outcome.
Semaglutide is a copy of a natural after-meal hormone
Your gut makes an after-meal hormone called glucagon-like peptide-1, or GLP-1 [15]. Semaglutide is a 31-amino-acid string, which simply means linked protein building blocks. It matches human GLP-1 by about 94%. Its lab weight is 4,114 daltons; a dalton measures tiny molecules, not what the drug will do to you. Two changes make the medicine last. One at piece 8 blocks a cutting chemical called DPP-4. Another lets it cling to albumin, an abundant blood protein [15]. Doctors may use this GLP-1 drug for type 2 diabetes, weight care, or lower heart risk. A 2025 use covers one serious fatty liver disease.
The Semaglutide peptide stays far longer than your own hormone
Peptides are short strings of protein building blocks. The semaglutide peptide acts like a gut hormone called GLP-1. As blood sugar rises, your pancreas answers by releasing insulin. Your own message disappears in about two minutes because a cutting chemical called DPP-4 breaks it apart. The makers altered protein piece 8, which stops that quick cut. A second change lets the drug cling to a blood protein, so your kidneys remove it more slowly [15]. Its half-life is near one week [13][15]. Those lab labels won't tell you how you'll feel.
How does Semaglutide work after you eat
How does semaglutide work? It acts like a gut hormone called GLP-1. Your gut sends that hormone after a meal. As sugar climbs, your pancreas gets a nudge to release insulin. The medicine also holds back a second hormone responsible for pushing sugar upward. Your stomach passes food onward at a slower pace [5][15].
What we know about the brain comes from rodents, not people. Semaglutide reached parts of their brains tied to hunger. They took in less food and changed what they chose, while their energy use stayed the same [4]. That work may help explain a change in hunger, but it can't prove that your brain responds the same way. Research on alcohol use isn't settled either. Animal findings can't predict your result.
Semaglutide weight loss was greater than with a placebo
A large study called STEP 1 didn't include people with diabetes. It followed 1,961 adults with excess weight. With semaglutide 2.4 mg, their average weight change was -14.9% by week 68. An inactive shot called a placebo led to -2.4%. The difference was about 12.4 percentage points [1]. STEP 1 was part of a larger group of weight studies. Those also used 2.4 mg weekly in adults with excess weight. STEP 2 included people with type 2 diabetes [10].
A small added study found an important limit. Both fat and muscle went down [9]. That result led to more study of protein and strength work. It doesn't cancel the average semaglutide weight loss. Here's a question worth asking: how will we watch my strength while my weight changes? Your result won't be fixed by an average.
Heart and kidney harm fell in three large studies
Each study included a narrow group. SUSTAIN-6 followed 3,297 adults with type 2 diabetes and heart risk. Researchers counted death tied to the heart, a heart attack people survived, and a stroke people survived. Those events happened less often with semaglutide, while eye trouble tied to diabetes happened more often. A 95% range showed how much each estimate might vary [2].
A second study followed 17,604 adults with excess weight who had heart disease without diabetes. Their combined heart risk was 20% lower, with a 95% range around that estimate [3]. A third followed 3,533 adults with type 2 diabetes and damaged kidneys. It counted kidney failure, a 50% or greater loss of kidney work, and death tied to kidneys or the heart. That total fell 24%, with its own 95% range [6]. Another 95% range covered the eye finding. You'll want to ask which group comes closest to you.
Semaglutide vs tirzepatide showed a larger average change with tirzepatide
Only one weight study, called SURMOUNT-5, has compared semaglutide vs tirzepatide face to face. It included 751 adults. At 72 weeks, average weight loss was -20.2% with tirzepatide and -13.7% with semaglutide. The difference was about 6.5 percentage points [7]. Tirzepatide copies two gut hormones involved in appetite and blood sugar; doctors call them GIP and GLP-1. Semaglutide copies just GLP-1. Both groups lost much weight, but the tirzepatide average was larger. One study can't settle your choice.
Another study, called SUSTAIN 7, compared semaglutide with a weekly diabetes drug. Semaglutide lowered weight and the blood test showing about three months of sugar more [12]. A separate study checked for clashes with metformin, warfarin, atorvastatin, and digoxin. Doctors didn't find an important change [8]. Bring your pill list when asking about slower stomach emptying. That study couldn't cover every medicine.
Oral Semaglutide can help even though little reaches your blood
After pooling many studies, reviewers found the daily pill helped with blood sugar and weight. Heart results resembled those for GLP-1 medicines in type 2 diabetes [11]. GLP-1 is the gut hormone these drugs copy. A 2024 review found that semaglutide lasts long enough for a weekly shot [13]. The authors compared how much medicine reached the blood and how fast it left. Another source says about 94% of the drug matches that hormone. Yet only about 0.4-1% of the pill enters your blood, even with a protective ingredient [15]. That small amount explains why pill timing matters. Oral semaglutide describes the morning routine.